正文
芝加哥公共卫生专员朱莉·莫里塔博士（Julie Morita）表示，许可证新条例的颁布令人期待，芝加哥市府加强制药企业责任的管控，为居民创造了新的医药品获取保障，该项举措领先于全国。同时，这一改进将有助于确保医生和居民了解到所需药品的准确信息，减少过度滥用导致上瘾的可能性。
1. 定义
Definitions for terms used in these Rules can be found in Section 4-6-310 of the Municipal Code of Chicago. The following terms are further defined for the purposes of these Rules.
-
“BACP” means the Chicago Department of Business Affairs and Consumer Protection.
-
“CDPH” means the Chicago Department of Public Health.
-
“Health care professional” shall mean any physician or other health care practitioner who is licensed to provide health care services or to prescribe pharmaceutical or biologic products. However, health care professional shall not be interpreted to include health care practitioners who work exclusively with animals.
-
“Medical Science Liaison” means a person with an advanced science or medical degree who provides technical assistance to healthcare professionals and does not carry out a marketing or sales function. Medical Science Liaisons may also be known by other titles including but not limited to Medical Liaison, Medical Manager, Regional Scientific Manager, Clinical Liaison, and Scientific Affairs Manager.
-
“Ordinance” means Section 4-6-310 of the Municipal Code of Chicago.
-
“Pharmaceutical representative” means a person who markets or promotes pharmaceuticals to health care professionals and excludes Medical Science Liaisons.
2. 许可证要求
Per Section 4-6-310(b) of the Municipal Code of Chicago, a license is required to conduct business as a pharmaceutical representative in the City of Chicago for fifteen or more days per calendar year. A person conducting business as a pharmaceutical representative must show the license or an exact copy thereof when contacting a health care professional in person if the health care professional asks to see it.
As defined in the Code, a “pharmaceutical representative” means a person who markets or promotes pharmaceuticals to health care professionals.
